SAN JOSE, Calif., Feb. 15, 2011 /PRNewswire/ -- Baxano, Inc. (www.baxano.com) today announced the addition of George A. Harter, Jr. to the executive team at Baxano, Inc. As Chief Financial Officer, Mr. Harter will be responsible for Finance, Administration and Human Resources.
Mr. Harter served as the Chief Financial Officer for Acclarent, Inc. from 2005 to 2011, through its acquisition by Johnson & Johnson. From September 2003 to April 2005, Mr. Harter served as Chief Financial Officer for Velocimed, an interventional cardiology company. Prior to Velocimed, Mr. Harter held roles at other health care companies including Boston Scientific. Mr. Harter received his B.A. in Economics from the University of California, Los Angeles and his M.B.A. from Case Western Reserve University.
"George is a key senior executive hire who adds tremendous credibility to our already strong team," said Tony Recupero, President and CEO of Baxano, Inc. "In 2011, our focus on will be on rapidly growing our base of clinical experience. With his impressive background establishing and growing financial and operational systems, he will play a key role in our continuing full commercial launch of the iO-Flex System."
"Baxano's less invasive iO-Flex™ System holds great promise for many patients suffering from spinal stenosis and provides a cost-effective treatment alternative to health care providers and insurers. I am excited to join Baxano as they bring this compelling technology to market and look forward to leveraging my experience to build another robust commercial-stage medical device company," said Mr. Harter.
About Baxano, Inc.
Based in San Jose, CA, Baxano, Inc., (www.BAXANO.com) is focused on developing innovative solutions that restore spine function, preserve healthy tissue, and enable a better quality of life for patients. Baxano, Inc. is the developer of the iO-Flex™ System which is an advancement in surgical technology for central, lateral recess and foraminal lumbar stenosis. This unique technology uses thin, flexible instruments through an open exposure or a minimally invasive tube to provide precision lumbar decompression from the "inside out" ("iO"). This "over the wire" approach allows surgeons to address targeted impinging tissue with a non-implant, direct decompression, while preserving facet joint integrity. Up to four nerve roots may be decompressed through a single-point access using this system.
Note: Baxano™ and iO-Flex™ are trademarks and service marks of Baxano, Inc.
SOURCE Baxano, Inc.